ArticleCancer chemotherapy and pharmacology2023

Pharmacokinetics, safety, tolerability, and feasibility of apatinib in combination with gefitinib in stage IIIB-IV EGFR-mutated non-squamous NSCLC: a drug-drug interaction study.

Yuxiang Ma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.